On the Increase in Use of GLP-1s
GLP-1 agonists, which include Ozempic, Mounjaro, and Wegovy, are already FDA-approved for type-2 diabetes, weight loss, and heart disease. Research shows a 40-fold increase in these drugs from 2017 to 2021, estimating that roughly 2-3% of the United States is now on either Ozempic or Mounjaro. "Doctors must be conscious of these facts, and patients must be educated."
Social media use by patients with hypermobile EDS
There is an enormous capacity for how social media in our current age can be utilized. In cases of chronic diseases such as Ehlers-Danlos Syndrome (EDS),
Ethical Challenges of Ozempic for Weight-Loss Use
The rise in demand for Ozempic has caused ongoing ethical concerns such as known adverse effects, unknown long-term health consequences, accessibility, and economic challenges. "With
The Value of the Holocaust in Medical Education
A brief summary and response to the 2024 Silvers' Annual Lecture by the same name.
Dangerous Ignorance: What Patients Don’t Understand about Pharmacogenomics
Peter Schwartz, MD, PhD., writes about the emerging importance of pharmacogenomics as well as current shortcomings in patients' understanding of pharmacogenomic testing results.
NaloxBoxes
Read all about the effects and ethics of the new NaloxBox at IUPUI, a Narcan distribution machine that's saving lives!
Doyle Publishes in Health Affairs on Personal Experience with Decision Aids
Tom Doyle, PhD, a postdoctoral fellow from the Center for Bioethics, reflects on his recent publication in Health Affairs on his personal experience with Hodgkin's
Faculty bringing a new focus on ethics, diversity, equity and inclusion in the anatomy field
As a child, Amber Comer, JD, PhD was close with her grandfather. A Holocaust survivor, he lived with her family and told her stories about
A Conversation about Fortitude by Kurt Vonnegut
On Wednesday, October 13, 2021, IU Center for Bioethics, Medical Humanities and Health Studies Program at IU, and The Charles
Engaging in Research with/in Rural Communities
On September 12, 2021, Dr. Katharine Head delivered a TREATs talk entitled "Engaging in Research with/in Rural Communities." Click to find out more about Dr.